help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on August 3, 2006, doi:10.1164/rccm.200509-1374OC

Am. J. Respir. Crit. Care Med., Volume 174, Number 8, October 2006, 886-893

A more recent version of this article appeared on October 15, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200509-1374OCv1
174/8/886    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuji, T.
Right arrow Articles by Nagai, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuji, T.
Right arrow Articles by Nagai, A.

Submitted on September 4, 2005
Accepted on August 3, 2006

Alveolar Cell Senescence in Pulmonary Emphysema Patients

Takao Tsuji1, Kazutetsu Aoshiba1*, and Atsushi Nagai1

1 First Department of Medicine, Tokyo Women's Medical University, Tokyo, Japan

* To whom correspondence should be addressed. E-mail: kaoshiba{at}chi.twmu.ac.jp.

Rationale and Objectives: The prevalence of COPD is age-dependent, suggesting an intimate relationship between the pathogenesis of COPD and aging. In this study we investigated whether the senescence of alveolar epithelial and endothelial cells is accelerated in emphysematous lungs. Methods: Samples of lung tissue were obtained from emphysema patients, asymptomatic smokers, and asymptomatic nonsmokers. Paraffin-embedded lung tissue sections were evaluated for cellular senescence by quantitative fluorescence in situ hybridization to assess telomere shortening, and by immunohistochemistry to assess the expression of senescence-associated cyclin-dependent kinase inhibitors. Tissue sections were also immunostained for proliferating cell nuclear antigen (PCNA), surfactant protein A, and CD31. Main Results: The emphysema patients had significantly higher percentages of type II cells positive for p16INK4a and p21CIP1/WAF1/Sdi1 than the asymptomatic smokers and nonsmokers. They had also significantly higher percentages of endothelial cells positive for p16INK4a than the asymptomatic smokers and nonsmokers, and higher percentages of endothelial cells positive for p21CIP1/WAF1/Sdi1 than the asymptomatic nonsmokers. Telomere length in alveolar type II cells and endothelial cells was significantly shorter in the emphysema patients than in the asymptomatic nonsmokers. The level of p16INK4a expression was negatively correlated with the level of PCNA expression. The level of alveolar cell senescence was positively correlated with airflow limitation. Conclusions: These results suggest that the senescence of alveolar epithelial and endothelial cells is accelerated in emphysema patients. Cellular senescence may explain the abnormal cell turnover that promotes the loss of alveolar cells in emphysematous lungs.


Key words: senescence, cyclin-dependent kinase inhibitors, telomere




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
W. MacNee, J. Maclay, and D. McAllister
Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2008; 5(8): 824 - 833.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. J. Barnes
Future Treatments for Chronic Obstructive Pulmonary Disease and Its Comorbidities
Proceedings of the ATS, December 1, 2008; 5(8): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Yao, S.-R. Yang, I. Edirisinghe, S. Rajendrasozhan, S. Caito, D. Adenuga, M. A. O'Reilly, and I. Rahman
Disruption of p21 Attenuates Lung Inflammation Induced by Cigarette Smoke, LPS, and fMLP in Mice
Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 7 - 18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. M. Tuder, J. H. Yun, and B. B. Graham
Cigarette Smoke Triggers Code Red: p21CIP1/WAF1/SDI1 Switches on Danger Responses in the Lung
Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 1 - 6.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
I Petrache, K Diab, K S Knox, H L Twigg III, R S Stephens, S Flores, and R M Tuder
HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism
Thorax, May 1, 2008; 63(5): 463 - 469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Churg, M. Cosio, and J. L. Wright
Mechanisms of cigarette smoke-induced COPD: insights from animal models
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L612 - L631.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. D. Wagner
Possible mechanisms underlying the development of cachexia in COPD
Eur. Respir. J., March 1, 2008; 31(3): 492 - 501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Mori, T. Nose, K. Ishitani, S. Kasagi, S. Souma, T. Akiyoshi, Y. Kodama, T. Mori, M. Kondo, S. Sasaki, et al.
Phosphodiesterase 4 inhibitor GPD-1116 markedly attenuates the development of cigarette smoke-induced emphysema in senescence-accelerated mice P1 strain
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L196 - L204.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. Agusti
Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don't Know (but Should)
Proceedings of the ATS, October 1, 2007; 4(7): 522 - 525.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev, July 1, 2007; 87(3): 1047 - 1082.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Vogelmeier and R. Bals
Chronic Obstructive Pulmonary Disease and Premature Aging
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1217 - 1218.
[Full Text] [PDF]


Home page
NEJMHome page
M. Y. Armanios, J. J.-L. Chen, J. D. Cogan, J. K. Alder, R. G. Ingersoll, C. Markin, W. E. Lawson, M. Xie, I. Vulto, J. A. Phillips III, et al.
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
N. Engl. J. Med., March 29, 2007; 356(13): 1317 - 1326.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. H. J. Vernooy, G. M. Moller, R. J. van Suylen, M. P. van Spijk, R. H. E. Cloots, P. H. Hoet, H. J. Pennings, and E. F. M. Wouters
Increased Granzyme A Expression in Type II Pneumocytes of Patients with Severe Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 464 - 472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S.-R. Yang, J. Wright, M. Bauter, K. Seweryniak, A. Kode, and I. Rahman
Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-{kappa}B in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L567 - L576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. M. Tuder
Aging, the Aging Lung, and Senile Emphysema Are Different
Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 198 - 198.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society
  ATS Best of the Web